Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 57

1.

Observer agreement and accuracy of 18F-sodium-fluoride PET/CT in the diagnosis of bone metastases in prostate cancer.

Zacho HD, Fonager RF, Nielsen JB, Haarmark C, Hendel HW, Johansen MB, Mortensen JC, Petersen LJ.

J Nucl Med. 2019 Sep 3. pii: jnumed.119.232686. doi: 10.2967/jnumed.119.232686. [Epub ahead of print]

PMID:
31481577
2.

No Added Value of 18F-Sodium Fluoride PET/CT for the Detection of Bone Metastases in Patients with Newly Diagnosed Prostate Cancer with Normal Bone Scintigraphy.

Zacho HD, Jochumsen MR, Langkilde NC, Mortensen JC, Haarmark C, Hendel HW, Jensen JB, Petersen LJ.

J Nucl Med. 2019 Dec;60(12):1713-1716. doi: 10.2967/jnumed.119.229062. Epub 2019 May 30.

PMID:
31147402
3.

The DAHANCA 32 study: Electrochemotherapy for recurrent mucosal head and neck cancer.

Plaschke CC, Johannesen HH, Hansen RH, Hendel HW, Kiss K, Gehl J, Wessel I.

Head Neck. 2019 Feb;41(2):329-339. doi: 10.1002/hed.25454. Epub 2018 Dec 15.

PMID:
30552847
4.

Adoptive cell therapy with tumor-infiltrating lymphocytes in patients with metastatic ovarian cancer: a pilot study.

Pedersen M, Westergaard MCW, Milne K, Nielsen M, Borch TH, Poulsen LG, Hendel HW, Kennedy M, Briggs G, Ledoux S, Nøttrup TJ, Andersen P, Hasselager T, Met Ö, Nelson BH, Donia M, Svane IM.

Oncoimmunology. 2018 Sep 26;7(12):e1502905. doi: 10.1080/2162402X.2018.1502905. eCollection 2018.

5.

68Ga-PSMA-PET/CT in comparison with 18F-fluoride-PET/CT and whole-body MRI for the detection of bone metastases in patients with prostate cancer: a prospective diagnostic accuracy study.

Dyrberg E, Hendel HW, Huynh THV, Klausen TW, Løgager VB, Madsen C, Pedersen EM, Pedersen M, Thomsen HS.

Eur Radiol. 2019 Mar;29(3):1221-1230. doi: 10.1007/s00330-018-5682-x. Epub 2018 Aug 21.

PMID:
30132104
6.

T cells isolated from patients with checkpoint inhibitor-resistant melanoma are functional and can mediate tumor regression.

Andersen R, Borch TH, Draghi A, Gokuldass A, Rana MAH, Pedersen M, Nielsen M, Kongsted P, Kjeldsen JW, Westergaard MCW, Radic HD, Chamberlain CA, Hölmich LR, Hendel HW, Larsen MS, Met Ö, Svane IM, Donia M.

Ann Oncol. 2018 Jul 1;29(7):1575-1581. doi: 10.1093/annonc/mdy139.

PMID:
29688262
7.

Prospective comparative study of 18F-sodium fluoride PET/CT and planar bone scintigraphy for treatment response assessment of bone metastases in patients with prostate cancer.

Fonager RF, Zacho HD, Langkilde NC, Fledelius J, Ejlersen JA, Hendel HW, Haarmark C, Moe M, Mortensen JC, Jochumsen MR, Petersen LJ.

Acta Oncol. 2018 Aug;57(8):1063-1069. doi: 10.1080/0284186X.2018.1438651. Epub 2018 Feb 15.

PMID:
29447047
8.

Diagnostic bone imaging in patients with prostate cancer: patient experience and acceptance of NaF-PET/CT, choline-PET/CT, whole-body MRI, and bone SPECT/CT.

Dyrberg E, Larsen EL, Hendel HW, Thomsen HS.

Acta Radiol. 2018 Sep;59(9):1119-1125. doi: 10.1177/0284185117751280. Epub 2018 Jan 9.

PMID:
29313360
9.

Diagnostic test accuracy study of 18F-sodium fluoride PET/CT, 99mTc-labelled diphosphonate SPECT/CT, and planar bone scintigraphy for diagnosis of bone metastases in newly diagnosed, high-risk prostate cancer.

Fonager RF, Zacho HD, Langkilde NC, Fledelius J, Ejlersen JA, Haarmark C, Hendel HW, Lange MB, Jochumsen MR, Mortensen JC, Petersen LJ.

Am J Nucl Med Mol Imaging. 2017 Nov 1;7(5):218-227. eCollection 2017.

10.

A prospective study comparing whole-body skeletal X-ray survey with 18F-FDG-PET/CT, 18F-NaF-PET/CT and whole-body MRI in the detection of bone lesions in multiple myeloma patients.

Dyrberg E, Hendel HW, Al-Farra G, Balding L, Løgager VB, Madsen C, Thomsen HS.

Acta Radiol Open. 2017 Oct 27;6(10):2058460117738809. doi: 10.1177/2058460117738809. eCollection 2017 Oct.

11.

Health-related quality of life in melanoma patients: Impact of melanoma-related limb lymphoedema.

Gjorup CA, Groenvold M, Hendel HW, Dahlstroem K, Drzewiecki KT, Klausen TW, Hölmich LR.

Eur J Cancer. 2017 Nov;85:122-132. doi: 10.1016/j.ejca.2017.07.052. Epub 2017 Sep 15.

PMID:
28918186
12.

Volume and Tissue Composition Changes Measured with Dual-Energy X-Ray Absorptiometry in Melanoma-Related Limb Lymphedema.

Gjorup CA, Hendel HW, Zerahn B, Dahlstroem K, Drzewiecki KT, Klausen TW, Hölmich LR.

Lymphat Res Biol. 2017 Sep;15(3):274-283. doi: 10.1089/lrb.2017.0013. Epub 2017 Sep 8.

PMID:
28885862
13.

Reference Values for Assessment of Unilateral Limb Lymphedema with Dual-Energy X-Ray Absorptiometry.

Gjorup CA, Hendel HW, Klausen TW, Zerahn B, Hölmich LR.

Lymphat Res Biol. 2018 Feb;16(1):75-84. doi: 10.1089/lrb.2016.0064. Epub 2017 May 9.

PMID:
28486005
14.

Gene therapy for patients with advanced solid tumors: a phase I study using gene electrotransfer to muscle with the integrin inhibitor plasmid AMEP.

Spanggaard I, Dahlstroem K, Laessoee L, Hansen RH, Johannesen HH, Hendel HW, Bouquet C, Attali P, Gehl J.

Acta Oncol. 2017 Jul;56(7):909-916. doi: 10.1080/0284186X.2017.1315171. Epub 2017 Apr 25.

PMID:
28438067
15.

Nuclear Molecular Imaging Strategies in Immune Checkpoint Inhibitor Therapy.

Guldbrandsen KF, Hendel HW, Langer SW, Fischer BM.

Diagnostics (Basel). 2017 Apr 21;7(2). pii: E23. doi: 10.3390/diagnostics7020023. Review.

16.

Routine X-ray of the chest is not justified in staging of cutaneous melanoma patients.

Gjørup CA, Hendel HW, Pilegaard RK, Willert CB, Hölmich LR.

Dan Med J. 2016 Dec;63(12). pii: A5317.

PMID:
27910800
17.

Repeatability of Volume and Regional Body Composition Measurements of the Lower Limb Using Dual-energy X-ray Absorptiometry.

Gjorup CA, Zerahn B, Juul S, Hendel HW, Christensen KB, Hölmich LR.

J Clin Densitom. 2017 Jan - Mar;20(1):82-96. doi: 10.1016/j.jocd.2016.08.009. Epub 2016 Sep 12.

PMID:
27634336
18.

Early 18F-FDG-PET/CT as a predictive marker for treatment response and survival in patients with metastatic colorectal cancer treated with irinotecan and cetuximab.

Skougaard K, Nielsen D, Jensen BV, Pfeiffer P, Hendel HW.

Acta Oncol. 2016 Sep - Oct;55(9-10):1175-1182. doi: 10.3109/0284186X.2016.1170197. Epub 2016 Aug 22.

PMID:
27548393
19.

Long-Lasting Complete Responses in Patients with Metastatic Melanoma after Adoptive Cell Therapy with Tumor-Infiltrating Lymphocytes and an Attenuated IL2 Regimen.

Andersen R, Donia M, Ellebaek E, Borch TH, Kongsted P, Iversen TZ, Hölmich LR, Hendel HW, Met Ö, Andersen MH, Thor Straten P, Svane IM.

Clin Cancer Res. 2016 Aug 1;22(15):3734-45. doi: 10.1158/1078-0432.CCR-15-1879. Epub 2016 Mar 22.

20.

Utility of interim and end-of-treatment PET/CT in peripheral T-cell lymphomas: A review of 124 patients.

El-Galaly TC, Pedersen MB, Hutchings M, Mylam KJ, Madsen J, Gang AO, Bøgsted M, de Nully Brown P, Loft A, Nielsen AL, Hendel HW, Iyer V, Gormsen LC.

Am J Hematol. 2015 Nov;90(11):975-80. doi: 10.1002/ajh.24128. Epub 2015 Aug 14.

21.

(18)F-fluorodeoxyglucose-positron emission tomography/computed tomography after one cycle of chemotherapy in patients with diffuse large B-cell lymphoma: results of a Nordic/US intergroup study.

Mylam KJ, Kostakoglu L, Hutchings M, Coleman M, Lamonica D, Czuczman MS, Diehl LF, Nielsen AL, Jensen P, Loft A, Hendel HW, Iyer V, Leppä S, Jyrkkiö S, Holte H, Eriksson M, Gillstrøm D, Hansen PB, Seppänen M, Hjorthaug K, Brown Pde N, Pedersen LM.

Leuk Lymphoma. 2015 Jul;56(7):2005-12. doi: 10.3109/10428194.2014.975800. Epub 2014 Nov 20.

PMID:
25330442
22.

CT versus FDG-PET/CT response evaluation in patients with metastatic colorectal cancer treated with irinotecan and cetuximab.

Skougaard K, Johannesen HH, Nielsen D, Schou JV, Jensen BV, Høgdall EV, Hendel HW.

Cancer Med. 2014 Oct;3(5):1294-301. doi: 10.1002/cam4.271. Epub 2014 Jun 18.

23.

Dual time point imaging fluorine-18 flourodeoxyglucose positron emission tomography for evaluation of large loco-regional recurrences of breast cancer treated with electrochemotherapy.

Matthiessen LW, Johannesen HH, Skougaard K, Gehl J, Hendel HW.

Radiol Oncol. 2013 Oct 8;47(4):358-65. doi: 10.2478/raon-2013-0054. eCollection 2013.

24.
25.

Comparison of EORTC criteria and PERCIST for PET/CT response evaluation of patients with metastatic colorectal cancer treated with irinotecan and cetuximab.

Skougaard K, Nielsen D, Jensen BV, Hendel HW.

J Nucl Med. 2013 Jul;54(7):1026-31. doi: 10.2967/jnumed.112.111757. Epub 2013 Apr 9.

26.
27.

Electrochemotherapy for large cutaneous recurrence of breast cancer: a phase II clinical trial.

Matthiessen LW, Johannesen HH, Hendel HW, Moss T, Kamby C, Gehl J.

Acta Oncol. 2012 Jul;51(6):713-21. doi: 10.3109/0284186X.2012.685524. Epub 2012 Jun 26.

PMID:
22731832
28.

FDG PET scans as evaluation of clinical response to dendritic cell vaccination in patients with malignant melanoma.

Engell-Noerregaard L, Hendel HW, Johannesen HH, Alslev L, Svane IM.

Cancer Immunol Immunother. 2013 Jan;62(1):17-25. doi: 10.1007/s00262-012-1306-5. Epub 2012 Jun 22.

PMID:
22722450
29.

Observer variability in a phase II trial - assessing consistency in RECIST application.

Skougaard K, McCullagh MJ, Nielsen D, Hendel HW, Jensen BV, Johannesen HH.

Acta Oncol. 2012 Jul;51(6):774-80. doi: 10.3109/0284186X.2012.667149. Epub 2012 Mar 21.

PMID:
22432439
30.

Positron emission tomography-computed tomography has a clinical impact for patients with cervical cancer.

Sandvik RM, Jensen PT, Hendel HW, Palle C.

Dan Med Bull. 2011 Mar;58(3):A4240.

PMID:
21371401
31.

[Indication for iodine-123 in scintigraphy of the thyroid gland].

Andersen KF, Hendel HW.

Ugeskr Laeger. 2011 Jan 31;173(5):354-5. Danish.

PMID:
21276401
32.

Malignant pheochromocytomas and paragangliomas - the importance of a multidisciplinary approach.

Andersen KF, Altaf R, Krarup-Hansen A, Kromann-Andersen B, Horn T, Christensen NJ, Hendel HW.

Cancer Treat Rev. 2011 Apr;37(2):111-9. doi: 10.1016/j.ctrv.2010.07.002. Epub 2010 Aug 2. Review.

PMID:
20675056
33.
34.

Multimodality imaging in a patient with adrenocortical carcinoma leading to peptide receptor radionuclide therapy.

Andersen KF, Mellemgaard A, Hendel HW.

Clin Nucl Med. 2009 Aug;34(8):543-8. doi: 10.1097/RLU.0b013e3181abb74e. No abstract available.

PMID:
19617743
35.

Pancreatic ascites due to rupture of a mucinous cystic neoplasm.

Bergenfeldt M, Poulsen IM, Hendel HW, Serizawa RR.

Acta Oncol. 2008;47(5):978-81. No abstract available.

PMID:
17917820
36.

[Retroperitoneal sarcoma: a multispecialist effort].

Andersen M, Horn T, Krarup-Hansen A, Nørgård H, Hendel HW, Bergenfeldt M.

Ugeskr Laeger. 2007 Aug 20;169(34):2786-7. Danish.

PMID:
17878019
37.

Circulating levels of TNF-alpha and IL-6-relation to truncal fat mass and muscle mass in healthy elderly individuals and in patients with type-2 diabetes.

Pedersen M, Bruunsgaard H, Weis N, Hendel HW, Andreassen BU, Eldrup E, Dela F, Pedersen BK.

Mech Ageing Dev. 2003 Apr;124(4):495-502.

PMID:
12714258
38.

99mTc-aprotinin scintigraphy in amyloidosis.

Schaadt BK, Hendel HW, Gimsing P, Jønsson V, Pedersen H, Hesse B.

J Nucl Med. 2003 Feb;44(2):177-83.

39.

Endoscopic retrograde cholangiopancreatography causes reduced myocardial blood flow.

Christensen M, Hendel HW, Rasmussen V, Højgaard L, Schulze S, Rosenberg J.

Endoscopy. 2002 Oct;34(10):797-800.

PMID:
12244501
40.

Utility of planar bone scintigraphy to distinguish benign osteochondromas from malignant chondrosarcomas.

Hendel HW, Daugaard S, Kjaer A.

Clin Nucl Med. 2002 Sep;27(9):622-4.

PMID:
12192277
41.

Are soft tissue composition of bone and non-bone pixels in spinal bone mineral measurements by DXA similar? Impact of weight loss.

Svendsen OL, Hendel HW, Gotfredsen A, Pedersen BH, Andersen T.

Clin Physiol Funct Imaging. 2002 Jan;22(1):72-7.

PMID:
12003104
42.

Skeletal muscle mitochondrial function and exercise capacity in HIV-infected patients with lipodystrophy and elevated p-lactate levels.

Røge BT, Calbet JA, Møller K, Ullum H, Hendel HW, Gerstoft J, Pedersen BK.

AIDS. 2002 May 3;16(7):973-82.

PMID:
11953463
43.

Accelerated postoperative recovery programme after colonic resection improves physical performance, pulmonary function and body composition.

Basse L, Raskov HH, Hjort Jakobsen D, Sonne E, Billesbølle P, Hendel HW, Rosenberg J, Kehlet H.

Br J Surg. 2002 Apr;89(4):446-53.

PMID:
11952586
44.

Extraosseous accumulation of Tc-99m diphosphonate.

Hendel HW, Buhl T, Mortensen J, Toft LV, Hesse B.

Clin Nucl Med. 2000 Oct;25(10):844-6. No abstract available.

PMID:
11043739
45.

[Orlistat: medically induced malabsorption of the fat in the treatment of severe obesity].

Hendel HW, Andersen T.

Ugeskr Laeger. 1999 Nov 1;161(44):6068-72. Review. Danish. No abstract available.

PMID:
10778347
46.

Fasting gall bladder volume and lithogenicity in relation to glucose tolerance, total and intra-abdominal fat masses in obese non-diabetic subjects.

Hendel HW, Højgaard L, Andersen T, Pedersen BH, Paloheimo LI, Rehfeld JF, Gotfredsen A, Rasmussen MH.

Int J Obes Relat Metab Disord. 1998 Apr;22(4):294-302.

PMID:
9578233
47.

[A clinical physiologist and nuclear medicine on the Internet].

Hendel HW.

Ugeskr Laeger. 1997 Nov 10;159(46):6813. Danish. No abstract available.

PMID:
9411992
48.

[Medicine on the Internet].

Hendel JW, Christensen TB, Hendel HW.

Ugeskr Laeger. 1997 Mar 24;159(13):1911-4. Danish. No abstract available.

PMID:
9123626
49.

[Search engines--who, what, how].

Hendel HW, Hendel JW, Christensen TB.

Ugeskr Laeger. 1997 Mar 10;159(11):1587-9. Danish. No abstract available.

PMID:
9092138
50.

[Internet--can it be used for congress preparations?].

Hendel JW, Christensen TB, Hendel HW.

Ugeskr Laeger. 1997 Feb 17;159(8):1072-5. Danish. No abstract available.

PMID:
9072849

Supplemental Content

Loading ...
Support Center